We are live on
!
Find out more
EAM
EFG Asset Management Portfolio holdings
AUM
$773M
1-Year Est. Return
40.1%
This Fund
S&P 500
This Quarter
Est. Return
-11.64%
1 Year Est. Return
+40.1%
3 Year Est. Return
+211.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$667M
AUM Growth
-$99.6M
(-13%)
Cap. Flow
+$153M
Cap. Flow
% of AUM
22.96%
Top 10 Holdings %
Top 10 Hldgs %
18.56%
Holding
204
New
29
Increased
52
Reduced
104
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Ultra Semiconductors
USD
|
+$155M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$9.35M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
+$5.97M |
| 4 |
CRISPR Therapeutics
CRSP
|
+$4.78M |
| 5 |
Perrigo
PRGO
|
+$3.32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MASI
Masimo
MASI
|
+$6.62M |
| 2 |
GXO Logistics
GXO
|
+$4.47M |
| 3 |
Expeditors International
EXPD
|
+$3.93M |
| 4 |
Teladoc Health
TDOC
|
+$3.51M |
| 5 |
Novavax
NVAX
|
+$2.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 40.34% |
| 2 | Technology | 21.71% |
| 3 | Consumer Discretionary | 13.19% |
| 4 | Industrials | 7.61% |
| 5 | Financials | 6.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGEN
1
DELISTED
Seagen Inc. Common Stock
SGEN
| $17M | 2.55% |
118,127
+1,757
| +2% | +$238K |
|
2
Idexx Laboratories
IDXX
$43B
| $15.8M | 2.37% |
28,867
-847
| -3% | -$446K |
|
3
Apple
AAPL
$4.79T
| $13.4M | 2% |
76,530
-15,788
| -17% | -$2.65M |
|
4
Blackstone
BX
$150B
| $13M | 1.95% |
102,261
-3,976
| -4% | -$485K |
|
5
Halozyme
HALO
$9.23B
| $11.7M | 1.76% |
294,413
-1,243
| -0.4% | -$44.3K |
|
6
Veeva Systems
VEEV
$30B
| $11.7M | 1.76% |
55,274
+3,002
| +6% | +$651K |
|
7
Chipotle Mexican Grill
CMG
$41.3B
| $11M | 1.65% |
348,200
+15,300
| +5% | +$461K |
|
8
Align Technology
ALGN
$12.4B
| $10.2M | 1.52% |
23,329
+110
| +0.5% | +$53.5K |
|
|
HZNP
9
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $10.1M | 1.51% |
+95,899
| New | +$9.35M |
|
10
Expedia Group
EXPE
$31.3B
| $9.92M | 1.49% |
50,684
-6,287
| -11% | -$1.18M |
|
11
Intuitive Surgical
ISRG
$122B
| $9.86M | 1.48% |
32,652
-866
| -3% | -$253K |
|
12
Alphabet (Google) Class A
GOOGL
$4.17T
| $9.64M | 1.44% |
69,300
-12,960
| -16% | -$1.76M |
|
13
Palo Alto Networks
PANW
$273B
| $9.62M | 1.44% |
92,694
-9,342
| -9% | -$836K |
|
14
Amazon
AMZN
$2.63T
| $9.59M | 1.44% |
58,840
-3,540
| -6% | -$547K |
|
15
KLA
KLAC
$280B
| $9.31M | 1.4% |
254,480
-66,870
| -21% | -$2.5M |
|
|
16
ProShares Ultra Semiconductors
USD
$2.85B
| $9.14M | 1.37% |
36,570,676
+15,473,936
| +73% | +$155M |
|
17
Edwards Lifesciences
EW
$48.6B
| $9.12M | 1.37% |
77,411
-5,993
| -7% | -$672K |
|
18
Thermo Fisher Scientific
TMO
$196B
| $8.79M | 1.32% |
14,867
-2,088
| -12% | -$1.2M |
|
|
BPMC
19
DELISTED
Blueprint Medicines
BPMC
| $8.73M | 1.31% |
136,691
+23,976
| +21% | +$1.72M |
|
20
MongoDB
MDB
$24.5B
| $8.53M | 1.28% |
19,241
-1,056
| -5% | -$413K |
|
21
Xencor
XNCR
$1.45B
| $8.28M | 1.24% |
310,566
-496
| -0.2% | -$16K |
|
22
Tradeweb Markets
TW
$21.1B
| $8.28M | 1.24% |
94,317
-5,175
| -5% | -$449K |
|
23
Ulta Beauty
ULTA
$20.8B
| $8.08M | 1.21% |
20,284
-1,113
| -5% | -$419K |
|
24
Illumina
ILMN
$28.9B
| $8.07M | 1.21% |
23,727
+367
| +2% | +$124K |
|
25
Veracyte
VCYT
$4.63B
| $8.03M | 1.2% |
291,203
+28,823
| +11% | +$824K |
|
Similar funds
HWM
CP
BVDMP
MSAM
WA
PAS
NSEDCP
RAM
EFG Asset Management's Q1 2022 Portfolio in Review
As of Q1 2022, EFG Asset Management held 204 positions worth $667M, down 13% from $767M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
EFG Asset Management deployed $153M of net new capital in Q1 2022, opening 29 new positions and adding to 52 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 95,899 shares worth $10.1M.
By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 37% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was GXO Logistics, an estimated $4.47M trimmed.
- EFG Asset Management's largest Q1 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 95,899 shares worth $10.1M.
- EFG Asset Management added most to ProShares Ultra Semiconductors in Q1 2022, an estimated $155M increase.
- EFG Asset Management's biggest Q1 2022 reduction was GXO Logistics, cutting an estimated $4.47M.
- EFG Asset Management fully exited Masimo in Q1 2022, selling an estimated $6.62M.
- EFG Asset Management's ten largest holdings make up 19% of its $667M portfolio in Q1 2022.
- EFG Asset Management opened 29 new positions and closed 19 in Q1 2022.
- EFG Asset Management's portfolio value fell 13% quarter-over-quarter to $667M.
Based on EFG Asset Management's 13F filing for Q1 2022, filed 26 Apr 2022.